Out with the OLD, in with the NEW diabetes style
This diabetes drug recently got approved for OSA
Tirzepatide
False; DELIVER and EMPEROR-Preserved Trials
Incident to billing code
CPT 99211
Spironolactone
Aldactone
AHT
Annual Hospital Training
Metformin is required as a 1st line therapy before SGLT2i or GLP-1 initiation
False; ADA now prioritizes therapies for CVD, kidney and weight benefit independent of metformin use
SGLT2 inhibitors must be stopped if eGFR drops after initation
False
NYP Video Visit Billing Code
CPT 99211 with 95 modifiers
Enalapril
Vasotec
PCMH
Patient-Centered Medical Home
Weight management is a primary therapeutic goal in diabetes management
TRUE; ADA 2026 now has weight management as a primary goal in patients with diabetes alongside glycemic management. It is now specifically framed as disease-modifying rather than cosmetic.
ACE inhibitors should only be started if BP is uncontrolled
CGM initiation billing code
CPT 95249
Hydralazine
Apresoline
NCQA
National Committee for Quality Assurance
A1c is the primary metric for assessing diabetes control
FALSE; ADA 2026 emphasizes multidimensional approach including Time-in-Range, CV outcomes, kidney progression and weight trajectory.
Patients over the age of 75 with ASCVD should not receive high intensity statins
FALSE; ACC recommends individualized patient-centered decisions
Transitional Care Management Billing Code
CPT 99495
Glyburide
Micronase, Diabeta
HEDIS
Healthcare Effectiveness Data and Information Set
A systolic BP goal of <120 mmHg should be encouraged in diabetic individuals with high CV or kidney risk
True; New recommendation in ADA 2026 based on BPROAD and ESPIRIT trials
SGLT2 inhibitors provide kidney protection in only patients with diabetes
FALSE
DSME Billing 1-1 Code
CPT G0108
Methyldopa
Aldomet
HERCULES
Hospital Efficiency, Revenue Cycle, Clinical Utilization, Length of Stay, and Enhanced Sourcing